戻る Agenda
Assessing the Value of a Cure: Are HTA Approaches and Payment Models Fit for Purpose?
Session Chair(s)
Koen Torfs
Head of Market Access & Pricing
Actelion, Switzerland
In this session we discuss how to prove value, establish a price, payment models
Speaker(s)
Panel discussion
Charlotte Anderberg, PHD, MSC
Dental and Pharmaceutical Benefits Agency, Sweden
Pharmaceutical Assessor
Panel Discussion
Francis Arickx
National Institute for Health and Disability Insurance (RIZIV-INAMI), Belgium
Head of the Directorate Pharmaceutical Policy
Panel discussion
Michael Schlander
German Cancer Research Center (DKFZ), Germany
Head of the Division of Health Economics
Panel discussion
Steve Wooding
Janssen, United States
Head, Global Commercial and Market Access Strategy Organisation
Panel discussion
Olivier Wong, MD
Medi-Qualite Omega, France
CMO